March 10, 2020 / 11:41 AM / 20 days ago

BRIEF-Cadent Therapeutics Announces FDA Clearance Of IND Application And Dosing Of Subjects Of CAD-9303 For Schizophrenia

March 10 (Reuters) -

* CADENT THERAPEUTICS ANNOUNCES FDA CLEARANCE OF IND APPLICATION AND DOSING OF SUBJECTS OF CAD-9303 FOR SCHIZOPHRENIA Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below